Kazia Therapeutics Limited American Depositary Shares
XNAS:KZIA
6.82
$6.95 - 300.00
$5.04 - 13.00
$6.53
$7.08
$7.08
$6.78
17.4
2.86
240451
272416.7
1618790
Chart
TendieTensor AI Analysis
Company
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
Fundamentals
7
-0.550000
-2.029500
100
BBG000KC7878
BBG001SCPMJ4
1.62M
1.67M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own KZIA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.